Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.525NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.525NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.525NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.480NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.480NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.480NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.214NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.214NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.214NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.304NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.304NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.304NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.214.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.214.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.214.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.577NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.577NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.577NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.639NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.639NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.639NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.2.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.2.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AZ.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AZ.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AZ.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.270NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.270NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.270NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.227NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.227NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.227NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
U.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
U.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
U.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.236NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.236NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used